Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat COVID-19
The Medicines Patent Pool and Merck have entered into a licensing agreement to facilitate affordable access for molnupiravir, an investigational oral antiviral COVID-19 medicine, in 105 low- and middle-income countries.
Full story

















